» Articles » PMID: 39619010

Towards Understanding Deterioration in Systemic Right Ventricular Function in the Setting of Tricuspid Regurgitation: Is There a Point of No Return?

Overview
Authors
Affiliations
Soon will be listed here.
References
1.
Lewis M, van Dissel A, Kochav J, DiLorenzo M, Ginns J, Zemer-Wassercug N . Cardiac MRI predictors of adverse outcomes in adults with a systemic right ventricle. ESC Heart Fail. 2022; 9(2):834-841. PMC: 8934915. DOI: 10.1002/ehf2.13745. View

2.
Lai W, Gauvreau K, Rivera E, Saleeb S, Powell A, Geva T . Accuracy of guideline recommendations for two-dimensional quantification of the right ventricle by echocardiography. Int J Cardiovasc Imaging. 2008; 24(7):691-8. DOI: 10.1007/s10554-008-9314-4. View

3.
van der Bom T, Winter M, Bouma B, Groenink M, Vliegen H, Pieper P . Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation. 2012; 127(3):322-30. DOI: 10.1161/CIRCULATIONAHA.112.135392. View

4.
Stout K, Daniels C, Aboulhosn J, Bozkurt B, Broberg C, Colman J . 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018; 139(14):e637-e697. DOI: 10.1161/CIR.0000000000000602. View

5.
Fratz S, Chung T, Greil G, Samyn M, Taylor A, Valsangiacomo Buechel E . Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. J Cardiovasc Magn Reson. 2013; 15:51. PMC: 3686659. DOI: 10.1186/1532-429X-15-51. View